Infectious Diseases and Immunity in Global Health program (Research Institute of the McGill University Health Centre)
Montréal, Québec
Joined October 2015
- Tweets1.3K
- Following313
- Followers680
- Likes523
IDIGH retweeted
"We are delighted and honoured to welcome the CTN+ to the RI-MUHC. I am confident that this network will enhance Canada’s capacity to address HIV and STBBI from prevention to cure,” - Dr. Rhian Touyz, Executive Director and CSO, RI-MUHC.
tinyurl.com/mpbtxd7k
We are excited to introduce the next chapter in HIV and STBBI clinical trials research — the CTN+.
This renewed version of CTN, funded $25 million by the @CIHR_IRSC, is coordinated from the @RIMUHC1 and strengthened by regional hubs across the country.
hivnet.ubc.ca/news/2024/07/c…
IDIGH retweeted
Congratulations to Drs. Sapha Barkati and Marina Klein for receiving the 2023 FMSQ prize for best research paper!
mcgill.ca/x/UEu
IDIGH retweeted
#CAHR2024 - Abstract submission now open!
#ACRV2024 - Appel à abrégés!
myemail.constantcontact.com/…
IDIGH retweeted
Honoured to coauthor this article in Nature Reviews!
✅#Recompensation is a promising goal in patients with #NAFLD-related #cirrhosis.
👉nature.com/articles/s41575-0…
@mcgillu @cusm_muhc @CASLupdates @McGill_DOM @CNTRP @FRQS1 #WomenInMedicine @IDIGHProgram
Remember that the first objective in a patient with decompensated cirrhosis is achieving RECOMPENSATION.
This great article in @NatRevGastroHep reviews the mechanisms of recompensation in fatty liver.
@VirginiaHdezGea @GiadaSebastiani #livertwitter
dlvr.it/Sx2ngR
IDIGH retweeted
MI4 a le plaisir d'annoncer que l'inscription est maintenant ouverte pour notre 5ème symposium scientifique annuel!
-
MI4 is delighted to announce that registration is now open for our 5th Annual Scientific Symposium!
event.fourwaves.com/mi4sympo…
IDIGH retweeted
I have the opportunity to discuss the @PALACE_Trial #PENFAST during this @CSACI_ca webinar focused on #penicillinallergy - please join this accredited meeting tomorrow evening - Sept. 28 @ 7:30 PM EDT @CodeVie_Life @cusm_muh @McGill_DOM @AllergyMuhc
canadiansocietyofallergyandc…
IDIGH retweeted
Currently reading Guest Blog: The two-year journey of a patient–researcher and CTN postdoctoral fellow;url=hivnet.ubc.ca/news/2023/08/t…
IDIGH retweeted
Exciting news! Dr. Madhu Pai @paimadhu has been appointed as the inaugural Chair of the Department of Global and Public Health (DGPH), School of Population and Global Health (SPGH), Faculty of Medicine and Health Sciences (FMHS), #McGill University, effective Oct 1.
ALT Dr. Madhu Pai posing for a selfie at the McGill School of Population and Global Health
IDIGH retweeted
Thank you for sharing our research! This can have an impact on #penicillin #allergy worldwide @PALACE_Trial
Clinical trail helps those with penicillin allergy. montreal.citynews.ca/2023/07…
IDIGH retweeted
Are you passionate about research in infectious diseases and microbial threats to human health? Join the MI4 team and help guide us into our new chapter!
Details about the Co-Director posting can be found here: mcgill.ca/mi4/files/mi4/2023…
IDIGH retweeted
Intravenous Liposomal Amphotericin B Efficacy and Safety for Cutaneous and Mucosal Leishmaniasis: A Systematic Review and Meta-analysis academic.oup.com/ofid/articl…
IDIGH retweeted
Every year, over 10,000 Canadians are infected by Staph bloodstream infection, which can lead to sepsis.
Find out how Dr. Todd Lee’s #ClinicalTrial will help find new treatments for this severe bloodstream infection.
cihr-irsc.gc.ca/e/53357.html…
@RIMUHC1
ALT Dr. Todd Lee: "By combining patient care with practical clinical trials, we can truly work towards a continuously learning health system, such that we all leave it more informed than how we found it.”
IDIGH retweeted
Proud of my master student @WesalElgretli, featured by the @RIMUHC1 !
✅ in the DAAs era, important to appreciate cardiometabolic complications of #HCV beyond liver !
#livertwitter @CASLupdates @IDIGHProgram @cusm_muhc @CIHR_CTN @canhepc @CAHR_ACRV
👉rimuhc.ca/en/-/ri-muhc-train…
IDIGH retweeted
We @Can_NTDs had the pleasure of hosting Dr @SoceFallBirima at a 🇨🇦 CSO round table - exploring how Canadian orgs can integrate NTDs to support the WHO NTD Roadmap. Key words: local ownership, harmonized training, cross-cutting issues & a whole person approach to health.
IDIGH retweeted
Honoured to be promoted Full Professor and being the first woman in my Division to achieve this goal!!
Thanks to all who trusted in me. Looking forward to continue contributing to hepatology!
#livertwitter @CASLupdates #WomenInSTEM @McGill_DOM @IDIGHProgram @CIHR_CTN @cusm_muhc
IDIGH retweeted
Ambitious program aims to eliminate hepatitis C in #Montreal
Three physician-scientists from top hospitals in Montreal have created a new initiative - Montréal sans HépC
@muhcfoundation #hepatitisC #hepatitis #HepC @cusm_muhc @CIUSSS_COMTL @chumontreal
wp.me/p4jJoz-e5u
ALT (l) Dr. Marina Klein, Research Director, Division of Infectious Diseases and Chronic Viral Illness Service at the MUHC and co-founder of Montréal sans HépC. | (m) Dr. Julie Bruneau, Clinical scientist, Addiction Medicine, CHUM; and Canada Research Chair in Addiction Medicine and co-founder of Montréal sans HépC. | (r) Dr. Christina Greenaway, leader in the Division of Infectious Diseases at the Jewish General Hospital and co-founder of Montréal sans HépC.
IDIGH retweeted
On May 25th, don't miss @paimadhu's presentation on “Antibiotic use by primary care providers in low & middle-income countries: lessons from mystery client studies” at the 3rd annual McGill AMR Symposium!
Register by May 20th: mcgill.ca/amrcentre/events-0…
